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INTRODUCTION
Diabetic retinopathy is one of the leading causes of blindness in
many nations. Ocular microvascular complications can lead to
diabetic macular edema or proliferative diabetic retinopathy (PDR),
which leads to loss of sight. PCP’s, Optometrists,
Ophthalmologists, or Retinal Specialists can diagnose diabetic
retinopathy. Those providers can use the following diagnostic tools:
dilated eye exam, 7-field stereoscopic fundus photograph,
fluorescein angiography, or optical coherence tomography (OCT).
As of January 2015, within Lehigh Valley Physicians Group, the
data shows that out of the 24,861 patients diagnosed with diabetes
in need of eye exams, only 5,482 patients have received one.
Evidence shows that screening for diabetic retinopathy has
reduced the rate of visual loss by greater than 25%. In order to
improve the quality care of the diabetic patient population, how
quality is measured needs to be further analyzed and addressed.
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Analyze quality measurements implemented by the provider
and payer within LVHN through program manuals
Determine discrepancies within measurements
Detect areas of opportunity to implement change
Observe the influence of reimbursement and policy
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After analyzing the quality measurements and taking a deeper
look into the quality metric for diabetic eye exams, the overall
conclusion comes to the lack of standardization between
providers and payers. There needs to be a more unified way of
evaluating quality of care supported by evidence-based clinical
data.

Determined that the measurements were not standardized among
contracts. 85% of measurements were seen in 3 or less contracts
and 15% of measurements were standardized between 4 or more
contracts.
Observed that 78% of the quality measurements were process
based, and only 17% were outcome based. 5% were mixed.
There was a quality measurement for performing a diabetic eye
exam within the following contracts: LVPHO, CBC QIP, Highmark
MA, Highmark Senior Bundle, Highmark PCMH, CMS ACO, and
AmeriHealth PP. Out of these contracts, only three, LVPHO, CMS
ACO and AmeriHealth PP, expect both the eye exam itself and the
results of the exam to be documented. All other contracts only
require documentation of a performed exam.
Data is exchanged between provider and payer by claims through
coding or data extraction from EMR’s.

•

•

Ishikawa Diagram showing the different branches involved in conducting a
diabetic eye exam. These components all interplay in the quality of care
patients are receiving within the community.
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RESULTS
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Furthermore, one issue with measuring whether patients receive
diabetic eye exams is proper documentation. Since patients can
see a variety of providers for their eye exam, documentation gets
lost in the process. If patients see providers outside the system,
eye exams must manually be scanned and inputted into the
EMR. This process hurts both the patient and the hospital by not
being able to accurately track population health and reducing
reimbursement while increasing cost. Thus, the data presented
by Figure 4 to the left, could also be the result of improper
documentation, showing that it does not accurately reflect on how
the providers are meeting the needs of their patients.

Analyzed 246 quality measurements among the following
contracts: LVPHO, Highmark MA, Highmark Senior Bundle,
Highmark PCMH, CMS ACO, PQRS GPRO, CBC QIP,
AmeriHealth PerformPlus, and Aetna ACS.
Defined numerators and denominators per quality measurements
Ranked measurements by how common they were among the
contracts
Looked at the following measurement in further detail:
‘Comprehensive Diabetic Care: Eye Exam Performed’
Dissected workflow documents and Epic Tip Sheets
Learned about reimbursement models and its convoluted system

FURTHER INFORMATION
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Diabetic Ocular Ailments. Long-term diabetes commonly leads to diabetic
retinopathy, which then can become more severe. If not caught early and
managed, diabetic retinopathy can lead to blindness.
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LVPG’s Compliance on Diabetic QM’s. The graph above shows how LVPG is
performing on the diabetic eye exam (blue), diabetic foot exam (green), and
nephropathy screening (purple) quality measurements. It is clear that diabetic eye
exam compliance is significantly below both other diabetic QM’s, as well as the
group’s target goal of 57% (red line).

• Implementation of guidelines for proper segmentation of
providers who can perform diabetic eye exams is necessary
for improvement of the system
• The use of Telemedicine can help more individuals gain
access to diabetes management and other components of
healthcare
- E-consults and eReferrals can be used
• Further research should be conducted after implementation
of updated workflows and training for maximizing the use of
Epic
• This will allow better utilization of each member in the
system, reduce cost, better communication, and most
importantly, increase quality of patient-centered population
healthcare.
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As previously mentioned, majority of the quality measurements
seen in this study were process based, including the
measurement for diabetic eye exams. Therefore, majority payers
are incentivizing providers for ordering the exam rather than the
result (e.g. whether they had diabetic retinopathy, macular
degeneration, blindness, etc.). However, for our state of
healthcare to progress, not only do surrogate outcomes need to
be reported, but patient-oriented ones need to be as well. Payers
should additionally incentivize keeping patients healthier, thus
attribute reimbursement for outcomes that reflect a healthy
population (e.g. patients that are not blind or do not have
retinopathy as a result of diabetes). Focusing on patient-oriented
outcomes will not only improve current quality of care, but will
also emphasis preventive medicine. Unfortunately, this can only
be accomplished if there is a change in policy.
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Who should screen for diabetic retinopathy? The pyramid above shows providers
who could perform a digital eye exam and send it to be read or perform a
fundoscopy. Proper segmentation of not only the providers, but also the clinical
staff needs to be further analyzed.
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